OVERVIEW

Case Studies in HIV Prevention and Treatment of Persons Who Use Drugs is organized by American Academy of CME, Inc..

Release Date: October 11, 2023
Expiration Date: October 11, 2024

Description:
Prevention of HIV in individuals with substance use disorder (SUD) is vitally important from a public health perspective. People with SUD are significantly more vulnerable to contracting HIV, attributable to behaviors such as sharing needles and injection equipment, engaging in condomless sex, and impaired judgement. Furthermore, substance use can negatively affect medication adherence and engagement in healthcare, making it more challenging to treat and manage HIV in this population. This can lead to rapid disease progression, development of multi-drug resistance and increased morbidity and mortality. Effective prevention strategies such as harm reduction programs, substance use treatment, access to mental health services and access to pre-exposure prophylaxis (PrEP) are crucial in reducing HIV transmission rates among individuals with SUD. Addressing both SUD and HIV prevention simultaneously, through a team-based integrated model of care, can both improve health outcomes of infected individuals and contribute to broader efforts to curb the HIV epidemic.

Learning Objectives

After participating in the activity, learners should be better able to:

  • Identify the specific behaviors and risk factors associated with substance use disorder (SUD) that contribute to an increased risk of HIV transmission.
  • Explain the significance of addressing HIV prevention and SUD concurrently through an integrated care model to improve uptake of HIV prevention tools in this population.
  • Identify barriers and facilitators for HIV prevention in individuals with SUD.
Credits

Accreditation and Credit Designation:
In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians:
American Academy of CME, Inc., designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Nurses:
American Academy of CME, Inc., designates this educational activity for 1.00 ANCC contact hours.

California
Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.00 contact hours.

Physician Assistants:
American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until October 11, 2024. PAs should only claim credit commensurate with the extent of their participation.

  • 1 AMA PRA Category 1 Credit™
  • 1 Contact Hours
  • TARGET AUDIENCE

    PhysicianPhysician AssistantFamily MedicineNurse Practitioners

    SPECIALITIES

    Infectious Disease

    RELATED ONLINE COURSES

    Webcast

    Emergency Medicine
    More actions
    US$200

    Webcast

    Pediatrics
    28 AMA PRA Category 1 Credits™
    More actions
    US$910